# Genomic Risk in Retroperitoneal Sarcoma

> **NCT06436846** · — · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Retroperitoneal Liposarcoma
- Soft Tissue Sarcoma

## Interventions

- **OTHER:** Biospecimen sample collection during standard-of-care surgery

## Key facts

- **NCT ID:** NCT06436846
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-07
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06436846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06436846, "Genomic Risk in Retroperitoneal Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06436846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*